These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 12453746)

  • 21. Venlafaxine versus sertraline for major depressive disorder.
    Wise TN; Sheridan MJ
    J Clin Psychiatry; 2000 Nov; 61(11):873-4. PubMed ID: 11105744
    [No Abstract]   [Full Text] [Related]  

  • 22. Cost and effectiveness of venlafaxine extended-release and selective serotonin reuptake inhibitors in the acute phase of outpatient treatment for major depressive disorder.
    Trivedi MH; Wan GJ; Mallick R; Chen J; Casciano R; Geissler EC; Panish JM
    J Clin Psychopharmacol; 2004 Oct; 24(5):497-506. PubMed ID: 15349005
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High venlafaxine serum levels after prior fluoxetine medication.
    Gerbaulet M; Engel A; Hiemke C; Dahmen N
    J Clin Psychopharmacol; 2012 Apr; 32(2):295-7. PubMed ID: 22388163
    [No Abstract]   [Full Text] [Related]  

  • 24. Antidepressants.
    Frazer A
    J Clin Psychiatry; 1997; 58 Suppl 6():9-25. PubMed ID: 9227669
    [No Abstract]   [Full Text] [Related]  

  • 25. New antidepressants for older people: a critical review of the evidence base.
    Katona C
    Encephale; 2008 Apr; 34 Suppl 2():S71-S76. PubMed ID: 18675006
    [No Abstract]   [Full Text] [Related]  

  • 26. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors.
    Thase ME; Entsuah AR; Rudolph RL
    Br J Psychiatry; 2001 Mar; 178():234-41. PubMed ID: 11230034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Venlafaxine: Successful treatment in impulsive disorders.
    Camardese G; Picello A; Bria P
    Psychiatry Clin Neurosci; 2008 Apr; 62(2):241-2. PubMed ID: 18412851
    [No Abstract]   [Full Text] [Related]  

  • 28. Venlafaxine: a 2003 update.
    Gutierrez MA; Stimmel GL; Aiso JY
    Clin Ther; 2003 Aug; 25(8):2138-54. PubMed ID: 14512125
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Venlafaxine extended-release: a review of its use in the management of major depression.
    Wellington K; Perry CM
    CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Placebo-controlled inpatient comparison of venlafaxine and fluoxetine for the treatment of major depression with melancholic features.
    Sheehan DV; Nemeroff CB; Thase ME; Entsuah R;
    Int Clin Psychopharmacol; 2009 Mar; 24(2):61-86. PubMed ID: 19238088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The treatment of SSRI-resistant depression in adolescents (TORDIA): in search of the best next step.
    Brent DA
    Depress Anxiety; 2009; 26(10):871-4. PubMed ID: 19798756
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative efficacy between venlafaxine and SSRIs: a pooled analysis of patients with depression.
    Stahl SM; Entsuah R; Rudolph RL
    Biol Psychiatry; 2002 Dec; 52(12):1166-74. PubMed ID: 12488062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A possible case of venlafaxine-induced Stevens-Johnson syndrome.
    Weiss NT; Jones L; Chamberlain JC
    J Clin Psychiatry; 2004 Oct; 65(10):1431-3. PubMed ID: 15491252
    [No Abstract]   [Full Text] [Related]  

  • 34. Differential physiological effects of a low dose and high doses of venlafaxine in major depression.
    Debonnel G; Saint-André E; Hébert C; de Montigny C; Lavoie N; Blier P
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):51-61. PubMed ID: 16690006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of venlafaxine in patients with major depressive disorder who have unsustained or no response to selective serotonin reuptake inhibitors: an open-label, uncontrolled study.
    Kaplan EM
    Clin Ther; 2002 Jul; 24(7):1194-200. PubMed ID: 12182262
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression.
    Costa e Silva J
    J Clin Psychiatry; 1998 Jul; 59(7):352-7. PubMed ID: 9714263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hemorrhages during escitalopram-venlafaxine-mirtazapine combination treatment of depression.
    Benazzi F
    Can J Psychiatry; 2005 Mar; 50(3):184. PubMed ID: 15830829
    [No Abstract]   [Full Text] [Related]  

  • 38. Escitalopram in the treatment of major depressive disorder: clinical efficacy, tolerability and cost-effectiveness vs. venlafaxine extended-release formulation.
    Llorca PM; Fernandez JL
    Int J Clin Pract; 2007 Apr; 61(4):702-10. PubMed ID: 17394446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sertraline versus fluoxetine in the treatment of major depression: a combined analysis of five double-blind comparator studies.
    Feiger AD; Flament MF; Boyer P; Gillespie JA
    Int Clin Psychopharmacol; 2003 Jul; 18(4):203-10. PubMed ID: 12817154
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Effects of venlafaxine extended release formulation on the clinical management of patients].
    Carrasco JL; Díaz-Marsá M; López-Ibor JJ
    Actas Esp Psiquiatr; 2005; 33(3):147-53. PubMed ID: 15918081
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.